ChatDocto
Find a doctor
Two-tone pharmaceutical capsule

ESORAL 40 mg

Esomeprazole · gastro-resistant capsules

B/8Oral use
15,475 DTRecorded public price · B/8
See all pack prices
Strength40 mg
Therapeutic classAPPAREIL DIGESTIF ET METABOLISME
ATC codeA02BC05

About this medicine

ESORAL 40 mg gastro-resistant capsules is listed in Tunisia's medicine catalog under the active ingredient Esomeprazole. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/8

    8 units in this pack

    Recorded public price15,475 DT
    AMM No.
    9233566
    CNAM code
    301366
    CNAM reference amount
    6,040 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

  • Pack · B/16

    16 units in this pack

    Recorded public price30,165 DT
    AMM No.
    9233563
    CNAM code
    301188
    CNAM reference amount
    12,080 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

  • Pack · B/28

    28 units in this pack

    Recorded public price48,710 DT
    AMM No.
    9233564
    CNAM code
    301189
    CNAM reference amount
    21,140 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formgastro-resistant capsules
Route of administrationOral use
LaboratoryLES LABORATOIRES MEDIS
OriginGeneric
ScheduleC
ATC codeA02BC05 — Ésoméprazole
Therapeutic classAPPAREIL DIGESTIF ET METABOLISME

Medicines with matching catalog characteristics

These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.

ACTIPP 40 mgGélules gastrorésistantesACT PHARMA · B/16
Recorded public price21,920 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026

ENOMERAL 40 40 mgGélules gastrorésistantesTAHA PHARMA · B/8
Recorded public price7,870 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026

ESOCALM 40 mgGélules gastrorésistantesADVANS PHARMA · B/7
Recorded public price7,585 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026

ESOCARE 40 mgGélules gastrorésistantesPHARMACARE · FL/7
Recorded public price10,840 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026

IPPSIUM 40 40 mgGélules gastrorésistantesOPALIA PHARMA · FL/14
Recorded public price26,355 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026

MESOPRAL 40 mgGélules gastrorésistantesTERIAK · FL/16
Recorded public price25,630 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026

NEXUS 40 mgGélules gastrorésistantesIBN AL BAYTAR · B/14
Recorded public price16,820 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026

RGEO 40 mgGélules gastrorésistantesSAIPH · B/14
Recorded public price11,370 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026